Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
¸ÞµðÄõð¹ÙÀ̽º (4695)
³»½Ã°æ (161)
ºÐÀÚ¿µ»ó/Á¶¿µÁ¦ (28)
½ÉÇ÷°üÀåÄ¡ (338)
¾È°ú±â±â (102)
ÀÇ·á¿ë ¿µ»óÁø´ÜÀåÄ¡ (416)
ÀÇ·á¿ë ÀÏȸ¿ëǰ (77)
Á¤Çü¿Ü°ú (341)
â»ó°ü¸® (163)
ü¿ÜÁø´ÜÀåÄ¡(IVD) (527)
ÃÊÀ½ÆÄ (55)
Ä¡°ú±â±â (176)
Ä«Å×ÅÍ (239)
ÇÙÀÇ·á (76)
ÇコÄɾî IT (314)
ȯÀÚ¸ð´ÏÅ͸µ (391)
CT/MRI/X-ray (173)
½ÃÀ庸°í¼­

Patient Monitoring Markets

¸®¼­Ä¡»ç Trimark Publications
¹ßÇàÀÏ 2009³â 10¿ù »óǰÄÚµå 100906
ÆäÀÌÁö Á¤º¸ 300 pages
°¡°Ý
US $ 3,400 £Ü 4,050,400 PDF by E-mail (Single User License)
US $ 6,800 £Ü 8,100,800 PDF By E-mail (Unlimited User License)


¿µ¹®¸ñÂ÷

Abstract

Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery rooms, outpatient care, transport, radiology, catheterization laboratories and gastroenterology departments, as well as for ambulatory, home and sleep screening applications. Patient monitoring can reduce the risk of infection and other complications, and it can assist in providing for patient comfort. Moreover, patient monitoring products measure, display and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices. The qualifier “at regular intervals over time” is used to distinguish patient monitoring devices from diagnostic kits and devices, which are typically used once or a few times to diagnose a patient' s condition and/or plan a course of therapy. Measured parameters include electrocardiogram (ECG), invasive and noninvasive blood pressure, pulse rate, pulse oximetry, body temperature, respiration rate, end-tidal CO2 and other specialized parameters. Products vary from specialized single-parameter instruments to monitors with the ability to measure multiple parameters and interface with other instruments. This TriMark Publications report assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities; discusses the potential benefits of the patient monitoring device market for various sectors of the medical community; establishes the current total market size and future growth of the patient monitoring device market and analyzes the current size and growth of various segments; provides current and forecasted market shares by the company; provides strategic recommendations for near-term business opportunities and assesses current commercial uses of the patient monitoring market.

Table of Contents

1. Introduction

  • 1.1 Objectives of this Report
  • 1.2 Scope of this Report
  • 1.3 Methodology
  • 1.4 Executive Summary
    • 1.4.1 The U.S. Medical Device Market
    • 1.4.2 Supply and Demand Fundamentals
    • 1.4.3 Sector Convergence
    • 1.4.4 Future Forecast
  • 1.5 The Leader in Patient Monitors
  • 1.6 U.S. Market for Patient Monitors
  • 1.7 Indian Market for Patient Monitors
  • 1.8 South East Asia' s Patient Monitoring Market

2. Market for Diabetes Monitoring

  • 2.1 Market for Blood Glucose Meters and Test Strips
  • 2.2 U.S. Market for Diabetes Care
  • 2.3 Self Monitoring Blood Glucose (SMBG) Device Market in Asia-Pacific
  • 2.4 Reviews of the Latest Glucose Meters
    • 2.4.1 Abbott Glucose Meters
    • 2.4.2 Glucose Meters from Bayer Healthcare
    • 2.4.3 Glucose Meters from LifeScan
    • 2.4.4 Glucose Meters from Roche
    • 2.4.5 Glucose Meters from Home Diagnostics

3. Sleep Market

  • 3.1 Sleep-Disordered Breathing (SDB) and Sleep Apnea
  • 3.2 Existing Therapies for Sleep Apnea
  • 3.3 Market for Sleep Apnea
  • 3.4 ResMed Corporation' s Sleep Business
    • 3.4.1 Airflow Generators
    • 3.4.2 ResMed' s Mask Systems and Diagnostic Products
    • 3.4.3 ResMed' s Competitors
  • 3.5 Pictorial Profile of a Few Sleep Products from ResMed
  • 3.6 Sleep Products from Philips Respironics, Inc.
  • 3.7 The Awakening of the Sleep Market
  • 3.8 New Investment in Sleep Apnea by GE and Intel

4. Pulse Oximetry

  • 4.1 Pulse Oximeters from Nellcor
  • 4.2 Pulse Oximeters from GE Healthcare
  • 4.3 Pulse Oximeters from Criticare Systems, Inc.
  • 4.4 Pulse Oximeters from Masimo Corporation
  • 4.5 Pulse Oximeters from Nihon Kohden
  • 4.6 Pulse Oximeters from Nonin Medical, Inc.
  • 4.7 An Estimation of Pulse Oximetry Gap

5. Capnography Market

  • 5.1 New Trends in Capnography
  • 5.2 European Market for Critical Care Blood Gas Monitoring
  • 5.3 Oridion and Capnography
  • 5.4 Philips Respironics and Capnography
  • 5.5 Smith Medical and Capnography
  • 5.6 Nonin Medical and Capnography

6. Anesthesia Monitors

  • 6.1 European Anesthesia Equipment Market
  • 6.2 The Sluggish Western European Market
  • 6.3 Sustained Growth in Eastern European Market
  • 6.4 Price Sensitivity
  • 6.5 Fierce Competition
  • 6.6 Fast Growth for Depth of Anesthesia Monitors
  • 6.7 Demands for Clinical Application Suites
  • 6.8 Hospital IT Aids Market Penetration of AIMS
  • 6.9 Future of Anesthesia Equipment Market in the E.U.
  • 6.10 Anesthesia Monitors from Dräger
  • 6.11 Anesthesia Monitors from GE Healthcare
  • 6.12 Anesthesia Monitors from Aspect Medical Systems
  • 6.13 Anesthesia Monitors from Mindray

7. Fetal Monitors

  • 7.1 Fetal Monitors from Analogic Corporation
  • 7.2 Fetal Monitors from GE Healthcare
  • 7.3 Fetal Monitor from Philips Healthcare
  • 7.4 Fetal Monitor from Cardinal Health
  • 7.5 Fetal Monitor from Nonin Medical
  • 7.6 Fetal Monitor from Spacelab Healthcare

8. Global Cardiovascular Devices Market

  • 8.1 Cardiovascular Monitoring
    • 8.1.1 Global Market for Ultrasound Devices
    • 8.1.2 Cardiovascular Diseases in the U.S.
    • 8.1.3 Market for Electrophysiology Devices in the U.S.
    • 8.1.4 Cardiovascular Diseases in Europe
    • 8.1.5 Cardiovascular Diseases in India
  • 8.2 Cardiology Equipment Market in India
  • 8.3 Cardiovascular Monitors from Biosense Webster (Johnson & Johnson)
  • 8.4 Cardiovascular Monitors from Boston Scientific
  • 8.5 Cardiovascular Monitor from Pulsion Medical Systems
  • 8.6 Cardiovascular products from GE Healthcare

9. Market for External Defibrillators

  • 9.1 Defibrillation
  • 9.2 Performance of Defibrillation
  • 9.3 Challenges Related to Defibrillation
  • 9.4 Types of Defibrillators
  • 9.5 Defibrillators from Cardiac Science Corporation
  • 9.6 Defibrillators from Physio-Control, Inc.

10. Blood Pressure Monitors

  • 10.1 A&D Medical/Life Source
  • 10.2 Omron Healthcare Co., Ltd.
  • 10.3 Japan Precision Instruments, Inc.
  • 10.4 Mabis Healthcare Duro-Med Industries (DMI)
  • 10.5 Medisana AG
  • 10.6 American Diagnostic Corporation

11. Holter Monitors

  • 11.1 Holter Monitors from Braemar, Inc.
  • 11.2 Holter Monitors from Fukuda Denshi
  • 11.3 Holter Monitor from Mortara Instrument
  • 11.4 Holter Monitor from Philips Healthcare
  • 11.5 Holter Monitor from Spacelab Healthcare
  • 11.6 Holter Monitor from Schiller AG

12. Market for Temperature Monitoring

13. Telehealth Market

  • 13.1 Intel and GE in Telehealth
    • 13.1.1 Usage of Remote Patient Monitoring in U.S. Healthcare Organizations in 2009
  • 13.2 Philips Healthcare
  • 13.3 Telehealth and Troubled Pregnancies
  • 13.4 Telehealth Devices from Tunstall

14. High Acuity Areas Monitoring Systems

  • 14.1 Patient Monitoring Systems in the High Acuity Area
  • 14.2 Advantages
  • 14.3 Market Scene
  • 14.4 Technology Trends
  • 14.5 Key Players
  • 14.6 Future of High Acuity Patient Monitors
  • 14.7 Product Profiles from Selected Companies

15. Global Home Healthcare Market

  • 15.1 Home Healthcare Market in the U.S.
  • 15.2 Wireless Monitoring in Home Healthcare

16. Profiles of Top 30 Medical Device Companies

  • 16.1 Johnson & Johnson
    • 16.1.1 Johnson & Johnson' s Consumer Healthcare Business
    • 16.1.2 Johnson & Johnson' s Medical Devices and Diagnostics Business
    • 16.1.3 Johnson & Johnson' s Pharmaceutical Business
    • 16.1.4 Research and Development
  • 16.2 GE Healthcare
    • 16.2.1 GE Healthcare' s Surgery Business
    • 16.2.2 GE Healthcare' s Healthcare Systems Business
    • 16.2.3 GE Healthcare' s Life Sciences Business
    • 16.2.4 GE Healthcare' s Medical Diagnostics Business
    • 16.2.5 GE Healthcare' s Healthcare IT Business
  • 16.3 Siemens Healthcare
  • 16.4 Medtronic
    • 16.4.1 Medtronic' s Cardiac Rhythm Disease Management (CRDM)
    • 16.4.2 Medtronic' s Spinal Products
    • 16.4.3 Medtronic' s Cardiovascular Products
    • 16.4.4 Medtronic' s Neuromodulation Products
    • 16.4.5 Medtronic' s Diabetes Products
    • 16.4.6 Medtronic' s Surgical Technologies Products
    • 16.4.7 Medtronic' s Performance in the U.S. and Non-U.S. markets
  • 16.5 Cardinal Health
    • 16.5.1 Cardinal' s Healthcare Supply Chain Services Business
    • 16.5.2 Cardinal' s Clinical and Medical Products Business
  • 16.6 Baxter International
    • 16.6.1 Baxter' s Bioscience Business
    • 16.6.2 Baxter' s Medication Delivery Business
    • 16.6.3 Baxter' s Renal Business
    • 16.6.4 Baxter' s Global Performance
  • 16.7 Philips Healthcare
    • 16.7.1 Philips' Cardiology Solutions
    • 16.7.2 Philips' Oncology Solutions
    • 16.7.3 Philips' Women' s Health Solutions
    • 16.7.4 Philips' Healthcare Performance
  • 16.8 Boston Scientific
  • 16.9 Covidien
  • 16.10 Becton Dickinson and Company
  • 16.11 Abbot Laboratories
  • 16.12 Stryker
    • 16.12.1 Hip Implant Systems
    • 16.12.2 Knee Implant Systems
    • 16.12.3 Trauma Implant Systems
    • 16.12.4 Spinal Implant Systems
    • 16.12.5 Craniomaxillofacial Implant Systems
    • 16.12.6 Surgical Equipment and Surgical Navigation Systems
    • 16.12.7 Endoscopic, Communications and Digital Imaging Systems
    • 16.12.8 Patient Handling and Emergency Medical Equipment
  • 16.13 B. Braun
  • 16.14 3M Healthcare
  • 16.15 Zimmer Holdings
  • 16.16 St. Jude Medical
    • 16.16.1 Atrial Fibrillation at St. Jude
    • 16.16.2 Connectivity at St. Jude
    • 16.16.3 Neuromodulation at St. Jude
  • 16.17 Hospira, Inc.
    • 16.17.1 Hospira' s Devices
  • 16.18 Smith & Nephew
    • 16.18.1 Smith & Nephew' s Orthopedics
    • 16.18.2 Smith & Nephew' s Endoscopy
    • 16.18.3 Smith & Nephew' s Advanced Wound Management
    • 16.18.4 Smith & Nephew' s R&D
  • 16.19 Danaher
    • 16.19.1 Danaher' s Medical Technologies
  • 16.20 Synthes
  • 16.21 Beckman Coulter, Inc.
  • 16.22 Olympus Medical Systems
  • 16.23 Fresenius Medical Care
  • 16.24 Alcon
  • 16.25 Terumo Cardiovascular Systems
    • 16.25.1 Terumo' s General Hospital Products Segment
    • 16.25.2 Terumo' s Cardiac and Vascular Products Segment
    • 16.25.3 Terumo' s Home Healthcare Products
    • 16.25.4 Terumo' s Performance in Geographic Segments
    • 16.25.5 Terumo' s R&D Programs
  • 16.26 C.R. Bard, Inc.
    • 16.26.1 Bard' s Vascular Products
    • 16.26.2 Bard' s Urology Products
    • 16.26.3 Bard' s Oncology Products
    • 16.26.4 Bard' s Surgical Specialties
  • 16.27 Oridion Medical
    • 16.27.1 Oridion' s Leadership in Capnography
    • 16.27.2 Smart Capnography
    • 16.27.3 Oridion' s Performance
  • 16.28 DENTSPLY International, Inc.
    • 16.28.1 DENTSPLY' s Products
  • 16.29 Dräger Medical AG & Co.
  • 16.30 Varian Medical Systems, Inc.
    • 16.30.1 Varian' s Oncology Systems
    • 16.30.2 Varian' s X-ray Products
    • 16.30.3 Varian' s R&D

17. The Invincible Medical Device Industry

  • 17.1 Baby Boomers and Incubating Innovations
  • 17.2 The Medical Device Industry in 2009
  • 17.3 Global Outlook for Medical Devices
  • 17.4 Outlook for Medical Devices in India
    • 17.4.1 Interventional Cardiology Market in India
    • 17.4.2 Molecular Diagnostics Market in India
    • 17.4.3 Penetration of Cardiology Informatics in India
  • 17.5 Outlook for Medical Devices in Russia
  • 17.6 Outlook for Medical Devices in China
    • 17.6.1 Penetration of Radiology Informatics in China
    • 17.6.2 In Vitro Diagnostics Market in China
    • 17.6.3 Impact of Recent Regulations in China
    • 17.6.4 Demand for High-end Products in China
    • 17.6.5 Forming Partnership with Chinese Companies
  • 17.7 South East Asia' s X-ray Market
  • 17.8 South East Asia' s Ultrasound Market
  • 17.9 Outlook for Medical Devices in Malaysia
  • 17.10 Outlook for Medical Devices in Indonesia
    • 17.10.1 Diagnostic Imaging Market in Indonesia
  • 17.11 Outlook for Medical Devices in Singapore
  • 17.12 Outlook for Medical Devices in Vietnam
  • 17.13 Outlook for Medical Devices in Denmark
  • 17.14 Outlook for Medical Devices in the U.K.

Appendix 1: The Global Medical Device Market

  • Appendix 1.1: Medical Device Market: U.S.
  • Appendix 1.2: Medical Device Market: France
  • Appendix 1.3: Medical Device Market: Turkey
  • Appendix 1.4: Medical Device Market: Romania

Appendix 2: Merger and Acquisition (M&A) in Medical Device Sector

  • Appendix 3: The Attractive Market for Investment
  • Appendix 3.1: Domination of Orthopedics
  • Appendix 3.2: Focus on Ophthalmic
  • Appendix 3.3: Patient Monitoring Portfolios
  • Appendix 3.4: Biosurgery and Wound care
  • Appendix 3.5: Cardiology Sector with a Healthy Heartbeat
  • Appendix 3.6: Deals in Diagnostics and Analytics
  • Appendix 3.7: Activities among Components Companies
  • Appendix 3.8: Future M&A Activity

Appendix 4: MDEA Award Winners and Patient Monitoring Products, 2008 and 2009

Appendix 5: Medical Equipment Market Trends in 2009

  • Appendix 5.1: Stellar Growth for Healthcare Information Technology
  • Appendix 5.2: Home Healthcare Equipment Market Poised for a Big Return
  • Appendix 5.3: Ongoing Trend towards Medical Tourism
  • Appendix 5.4: Medical Equipment Manufacturers Remain Stable Defying Recession
  • Appendix 5.5: Direct To Consumer Advertising Increases
  • Appendix 5.6: Healthcare Information Technology to Gain Attention in Emerging Economies
  • Appendix 5.7: Drug Eluting Stents on a Comeback Trail in the U.S.
  • Appendix 5.8: Hip Resurfacing Market to Get a Boost from Young Adults and Middle-aged Patients
  • Appendix 5.9: Cash Rich and Innovative Companies to Thrive in the Present Economic Scenario
  • Appendix 5.10: Products for Women' s Health, Minimally Invasive Surgery and Home Healthcare to Gain
  • Appendix 5.11: High Value and Low Value of Deals will be a Norm in M&A

INDEX OF FIGURES

  • Figure 1.1: Global Market for Patient Monitors, 2008-2015
  • Figure 1.2: U.S. Market for Patient Monitors, 2008-2015
  • Figure 1.3: Global Market Share for Patient Monitors by Company, 2007
  • Figure 1.4: Global Share of Patient Monitoring Market by Philips, 2007
  • Figure 1.5: Philips' Global Market Share in Patient Monitors, 2003-2007
  • Figure 1.6: GE' s Global Market Share in Patient Monitors, 2003-2007
  • Figure 1.7: Dräger' s Global Market Share in Patient Monitors, 2003-2007
  • Figure 1.8: Mindray' s Global Market Share in Patient Monitors, 2003-2007
  • Figure 1.9: Nihon Kohden' s Global Market Share in Patient Monitors, 2003-2007
  • Figure 1.10: Nihon Kohden' s Market for Patient Monitors, 2008
  • Figure 1.11: South East Asia' s Patient Monitor Market, 2007
  • Figure 2.1: The Global Diabetes Care Devices Market, 2008-2015
  • Figure 2.2: Prevalence of Diabetes in the Top Three Diabetic Countries, 2007 and 2025
  • Figure 2.3: Total Economic Cost of Diabetes in the U.S., 2007
  • Figure 2.4: Asia-Pacific SMBG Competitive Market Share, 2007
  • Figure 2.5: Chinese SMBG Competitive Market Share, 2007
  • Figure 2.6: Bayer' s Market for Diabetes Care Segment, 2006-2008
  • Figure 2.7: Johnson & Johnson' s Market in Diabetes Care, 2008
  • Figure 2.8: Roche' s Market in Diabetes Care Segment, 2008
  • Figure 2.9: Home Diagnostics' Market for Glucose Meters and Accessories, 2005-2008
  • Figure 3.1: Global Sleep Apnea Management Market, 2008-2012
  • Figure 3.2: ResMeds' s Market for CPAP and VPAP Flow Generators, 2006-2008
  • Figure 3.3: ResMed' s Market for Masks and Accessories, 2006-2008
  • Figure 3.4: ResMed' s Market for its Sleep Products in the Americas, 2006-2008
  • Figure 3.5: ResMed' s Market for its Sleep Products in Europe, 2006-2008
  • Figure 3.6: ResMed' s Market in Asia-Pacific and Rest of the World, 2006-2008
  • Figure 4.1: U.S. Pulse Oximetry Market Share by Company, 2008
  • Figure 4.2: Market Growth for U.S. Pulse Oximetry, 2008-2013
  • Figure 4.3: Market for Pulse Oximeters in the E.U., 2008-2015
  • Figure 4.4: Nellcor' s (Covidien) Market for Oximetry and Monitoring Products, 2006-2008
  • Figure 4.5: Masimo SET Installed Base, 2004-2008
  • Figure 5.1: E.U. Market for Critical Care Blood Gas Monitoring Products, 2008-2013
  • Figure 5.2: Oridion' s Capnography Market, 2004-2008
  • Figure 6.1: Global Anesthesia and Respiratory Devices Market, 2008-2015
  • Figure 6.2: Aspect' s Worldwide Total Installed Bases of Monitors and Modules, 2004-2008
  • Figure 6.3: Aspect' s Sensor Shipment, 2004-2008
  • Figure 8.1: Global Market for Cardiovascular Devices, 2008-2012
  • Figure 8.2: Global Market for Ultrasound Devices, 2008-2015
  • Figure 8.3: Direct and Indirect Costs of Heart Diseases in the U.S., 2009
  • Figure 8.4: U.S. Electrophysiology Device Market in the U.S., 2008-2015
  • Figure 8.5: European Market for Electrocardiography Products, 2008
  • Figure 8.6: Mortality Rate for CVD, 2007
  • Figure 8.7: Indian ECG Equipment Market by Unit, 2008
  • Figure 8.8: Indian ECG Equipment Market by Value, 2008
  • Figure 8.9: Boston' s Cardiology Market, 2008
  • Figure 8.10: Pulsion' s Dominance in Intensive Care Unit in Comparison to Competitors, 2008
  • Figure 9.1: Growth of Manual External Defibrillators, 2008-2012
  • Figure 9.2: Cardiac Science' s Market for Defibrillation Products, 2006-2008
  • Figure 13.1: Growth of Telehealth, 2010-2015
  • Figure 13.2: Telehealth Market, 2008-2012
  • Figure 13.3: Growth of Telehealth as Predicted by Intel and GE, 2008-2012
  • Figure 13.4: Remote Patient Monitoring in the U.S. Healthcare Organizations, 2009
  • Figure 14.1: Market Share of Multiparameter Monitoring Equipments by Company, 2008
  • Figure 14.2: Market Share Split among the Key Players in High Acuity Area Patient Monitors, 2008
  • Figure 15.1: Global Home Healthcare Market, 2008-2012
  • Figure 15.2: U.S. Market for Home Healthcare Products, 2008-2012
  • Figure 15.3: Patients Diagnosed with Common Welfare Diseases in Europe and the U.S., 2008
  • Figure 15.4: Global Blood Pressure Monitoring Market, 2008-2012
  • Figure 15.5: Global Blood Glucose Monitoring Market, 2008-2012
  • Figure 15.6: Global Lipid Monitoring Market, 2008-2012
  • Figure 16.1: Johnson & Johnson' s Consumer Segment Performance, 2008
  • Figure 16.2: Johnson & Johnson' s Medical Devices and Diagnostics Performance, 2008
  • Figure 16.3: Johnson & Johnson' s Pharmaceutical Business Performance, 2008
  • Figure 16.4: Johnson & Johnson' s R&D Expenditure, 2006-2008
  • Figure 16.5: GE Healthcare' s Performance, 2004-2008
  • Figure 16.6: Siemens' Business Performance in Healthcare Segment by Geography, 2008
  • Figure 16.7: Siemens' Business Performance in Healthcare Sector by Segment, 2008
  • Figure 16.8: Medtronic' s Cardiac Rhythm Disease Management Performance, 2008
  • Figure 16.9: Medtronic' s Spine Products Performance, 2008
  • Figure 16.10: Medtronic' s Cardiovascular Products Performance, 2008
  • Figure 16.11: Medtronic' s Surgical Technologies Products Performance, 2008
  • Figure 16.12: Medtronic' s U.S. and Non-U.S. Performance, 2008
  • Figure 16.13: Cardinal' s Overall Performance, 2006-2008
  • Figure 16.14: Cardinal' s Healthcare Supply Chain Services Performance, 2006-2008
  • Figure 16.15: Cardinal' s Clinical and Medical Products Performance, 2007 and 2008
  • Figure 16.16: Baxter' s Bioscience Business Performance, 2008
  • Figure 16.17: Baxter' s Medication Delivery Business Performance, 2008
  • Figure 16.18: Baxter' s Renal Business Performance, 2008
  • Figure 16.19: Baxter' s Global Performance, 2006-2008
  • Figure 16.20: Philips' Healthcare Performance, 2006-2008
  • Figure 16.21: Philips Healthcare Performance by Geography, 2008
  • Figure 16.22: Boston' s Global Performance, 2004-2008
  • Figure 16.23: Boston' s Performance in Cardiac Rhythm Management, 2007 and 2008
  • Figure 16.24: Boston' s Performance in Coronary Stent Systems, 2007 and 2008
  • Figure 16.25: Boston' s Performance in Endosurgery, 2007 and 2008
  • Figure 16.26: Boston' s Global Performance by Geography, 2006-2008
  • Figure 16.27: Covidien' s Global Performance, 2004-2008
  • Figure 16.28: Covidien' s R&D Expenditure, 2004-2008
  • Figure 16.29: Covidien' s Performance by Geographical Region, 2008
  • Figure 16.30: Covidien' s Performance in Medical Devices by Groups of Products, 2008
  • Figure 16.31: BD' s Global Performance, 2005-2008
  • Figure 16.32: BD' s Medical Segment: Performance by Sub-Segment, 2008
  • Figure 16.33: BD' s Diagnostic Segment: Performance, 2007 and 2008
  • Figure 16.34: BD' s Biosciences Segment: Performance, 2007 and 2008
  • Figure 16.35: BD' s U.S. and Non-U.S. Performance, 2008
  • Figure 16.36: Abbott' s Global Performance, 2004-2008
  • Figure 16.37: Abbott' s Performance: Vascular Segment, 2006-2008
  • Figure 16.38: Abbott' s Performance: Diagnostics Segment, 2006-2008
  • Figure 16.39: Abbott' s Performance: Pharmaceutical Segment, 2006-2008
  • Figure 16.40: Abbott' s Performance: Nutritional Segment, 2006-2008
  • Figure 16.41: Abbott' s R&D Expenditure, 2006-2008
  • Figure 16.42: Stryker' s Global Performance, 2006-2008
  • Figure 16.43: Stryker' s R&D Expenditure, 2006-2008
  • Figure 16.44: B. Braun' s Group Performance, 2006-2008
  • Figure 16.45: B. Braun' s Performance: Hospital Care Division, 2006-2008
  • Figure 16.46: B. Braun' s Performance: Aesculap Division, 2006-2008
  • Figure 16.47: B. Braun' s Performance: OPM Division, 2006-2008
  • Figure 16.48: B. Braun' s Performance: Avitum Division, 2006-2008
  • Figure 16.49: B. Braun' s Employees by Region, 2008
  • Figure 16.50: 3M Healthcare: Global Performance, 2006-2008
  • Figure 16.51: Zimmer' s Global Performance, 2006-2008
  • Figure 16.52: Zimmer' s Performance by Geographic Segment, 2008
  • Figure 16.53: Zimmer' s R&D Expenditure, 2006-2008
  • Figure 16.54: St. Jude' s Global Performance, 2006-2008
  • Figure 16.55: St. Jude' s Performance in Cardiac Rhythm Management, 2008
  • Figure 16.56: St. Jude' s Performance in its Cardiovascular Segment, 2008
  • Figure 16.57: St. Jude' s Performance in Atrial Fibrillation Products, 2006-2008
  • Figure 16.58: St. Jude' s Performance in Neuromodulation Products, 2006-2008
  • Figure 16.59: Hospira' s Global Performance, 2004-2008
  • Figure 16.60: Hospira' s Performance in the Americas, 2008
  • Figure 16.61: Hospira' s Performance in EMEA Region, 2008
  • Figure 16.62: Hospira' s Performance in APAC Region, 2008
  • Figure 16.63: Hospira' s R&D Investment, 2006-2008
  • Figure 16.64: Smith & Nephew' s R&D Expenditure, 2006-2008
  • Figure 16.65: Smith & Nephew' s Performance by Business Segment, 2008
  • Figure 16.66: Smith & Nephew' s Performance by Geographic Market, 2008
  • Figure 16.67: Danaher' s Performance by Geography, 2008
  • Figure 16.68: Danaher' s R&D Expenditure in its Medical Technologies, 2006-2008
  • Figure 16.69: Medical Technologies Performance: U.S. and Non-U.S., 2006-2008
  • Figure 16.70: Danaher' s Performance in Medical Technologies, 2006-2008
  • Figure 16.71: Synthes' Global Performance, 2004-2008
  • Figure 16.72: Synthes' Performance by Geographical Region, 2008
  • Figure 16.73: Beckman Coulter' s Global Performance, 2004-2008
  • Figure 16.74: Beckman Coulter' s Performance by Geographic Region, 2008
  • Figure 16.75: Olympus' Global Performance, 2004-2008
  • Figure 16.76: Olympus' Performance by Geographic Area, 2008
  • Figure 16.77: Olympus' Performance by Business Segments, 2008
  • Figure 16.78: Fresenius' Group Performance, 2004-2008
  • Figure 16.79: Fresenius' Performance by Geographic Region, 2008
  • Figure 16.80: Fresenius' Performance in Dialysis Products, 2007 and 2008
  • Figure 16.81: Fresenius Kabi' s Performance by Geographic Region, 2008
  • Figure 16.82: Alcon Laboratory' s Global Performance, 2004-2008
  • Figure 16.83: Alcon Laboratory' s Performance by Geographical Segment, 2008
  • Figure 16.84: Alcon Laboratory' s R&D Expenditure, 2004-2008
  • Figure 16.85: Alcon' s R&D Expenditure by Therapeutic Category, 2008
  • Figure 16.86: Alcon' s Global Surgical Market Share, 2004-2008
  • Figure 16.87: Alcon' s Global Market Share in Intraocular Lenses, 2004-2008
  • Figure 16.88: Alcon' s U.S. Contact Lens Care Solution Market Share, 2008
  • Figure 16.89: Terumo' s Performance: General Hospital Products Segment, 2004-2008
  • Figure 16.90: Terumo' s Performance: Cardiac and Vascular Products, 2004-2008
  • Figure 16.91: Terumo' s Performance: Home Healthcare Products, 2004-2008
  • Figure 16.92: Terumo' s Performance by Geographical Region, 2008
  • Figure 16.93: Terumo' s R&D Expenditure, 2004-2008
  • Figure 16.94: Bard' s Performance in Vascular Products, 2004-2008
  • Figure 16.95: Bard' s Performance in Urology Products, 2004-2008
  • Figure 16.96: Bard' s Performance in Oncology Products, 2004-2008
  • Figure 16.97: Bard' s Performance in Surgical Specialties, 2004-2008
  • Figure 16.98: Capnography Boards Sold by Oridion, 2004-2008
  • Figure 16.99: Oridion' s Performance, 2004-2008
  • Figure 16.100: Oridion' s Investment in R&D, 2006-2008
  • Figure 16.101: DENTSPLY' s Performance by Geographic Segment, 2008
  • Figure 16.102: DENTSPLY' s Global Performance, 2004-2008
  • Figure 16.103: Drager' s Performance by Region, 2008
  • Figure 16.104: Drager' s Business Performance in its Medical Division, 2008
  • Figure 16.105: Drager' s Medical Division R&D Expenditure, 2004-2008
  • Figure 16.106: Varian' s Performance in its Oncology Systems, 2006-2008
  • Figure 16.107: Performance of Varian' s Oncology Systems, 2008
  • Figure 16.108: Varian' s Performance in its X-ray Products, 2006-2008
  • Figure 16.109: Performance of Varian' s X-ray Products by Geographic Region, 2008
  • Figure 16.110: Varian' s R&D Expenditure, 2006-2008
  • Figure 17.1: Global Market for Medical Devices, 2008-2011
  • Figure 17.2: Market Growth for Medical Devices in India, 2008-2015
  • Figure 17.3: Market Growth for Cardiovascular Devices in India, 2008-2015
  • Figure 17.4: Market Growth for Orthopedic Devices in India, 2008-2015
  • Figure 17.5: Interventional Cardiology Market in India, 2008-2012
  • Figure 17.6: Indian Molecular Diagnostics Instruments and Reagent Market, 2008
  • Figure 17.7: Penetration of Cardiology Informatics in India, 2008
  • Figure 17.8: Growth of Market for Medical Devices in Russia, 2008-2013
  • Figure 17.9: Market Growth for Medical Devices in China, 2008-2013
  • Figure 17.10: The Market for Radiology IT in China, 2008
  • Figure 17.11: In Vitro Diagnostic Market in China, 2007-2010
  • Figure 17.12: China' s In Vitro Diagnostic Market Value, 2007
  • Figure 17.13: The Top Three Deadly Diseases in China, 2009
  • Figure 17.14: South East Asia' s X-ray Market, 2007
  • Figure 17.15: Growth of Ultrasound Market in South East Asia, 2007-2010
  • Figure 17.16: South East Asia' s Ultrasound Market Value, 2007
  • Figure 17.17: Percentage of Color Versus Black & White Units Installed in South East Asia, 2007
  • Figure 17.18: Market Growth for Medical Devices in Malaysia, 2008-2010
  • Figure 17.19: Market Growth for Medical Devices in Indonesia, 2008-2013
  • Figure 17.20: Indonesia' s Diagnostic Imaging Market, 2008
  • Figure 17.21: Market Growth for Medical Devices in Singapore, 2008-2012
  • Figure 17.22: Market Growth for Medical Devices in Vietnam, 2009-2014
  • Figure 17.23: Market Growth for Medical Devices in Denmark, 2009-2014
  • Figure 17.24: Market Growth for Medical Devices in the U.K., 2009-2014
  • Figure A1.1: U.S. Medical Device Exports, 2008
  • Figure A1.2: Total U.S. Medical Device Exports, 2007
  • Figure A1.3: Growth of Medical Device Market: France, 2008-2013
  • Figure A1.4: Export of Medical Devices from Turkey by Value, 2004-2008
  • Figure A1.5: Medical Device Market Growth: Romania, 2008-2013
  • Figure A5.1: U.S. Market Growth in Healthcare IT, 2007-2012
  • Figure A5.2: Growth of Global Home Healthcare Equipment Market, 2007-2012
  • Figure A5.3: Growth for Indian Medical Tourism, 2007-2012

INDEX OF TABLES

  • Table 2.1: Technical Information on FreeStyle Lite
  • Table 2.2: Technical Information for Freedom Lite
  • Table 2.3: Technical Information on Precision Xtra
  • Table 2.4: Technical Information for Contour
  • Table 2.5: Technical Information on Contour TS
  • Table 2.6: Technical Information on Breeze2
  • Table 2.7: Technical Information on OneTouch Ultra Mini
  • Table 2.8: Technical Information on OneTouch Ultra2
  • Table 2.9: Technical Information on OneTouch UltraSmart
  • Table 2.10: Technical Information on OneTouch UltraLink
  • Table 2.11: Technical Information on Accu-Chek Compact Plus
  • Table 2.12: Technical Information on Accu-Chek Aviva
  • Table 2.13: Technical Information on True2Go
  • Table 2.14: Technical Information on TRUEresult
  • Table 2.15: Technical Information on TRUEtrack
  • Table 2.16: Technical Information on TRUEread
  • Table 2.17: Technical Information on Sidekick
  • Table 3.1: ResMed' s Continuous Positive Airway Products
  • Table 3.2: ResMed' s Automatic Positive Airway Products
  • Table 3.3: ResMed' s Variable Positive Airway Products
  • Table 3.4: ResMed' s Ventilation Products
  • Table 3.5: ResMed' s Mask Systems and Diagnostic Products
  • Table 3.6: Sleep Recorders from ResMed
  • Table 4.1: Pulse Oximetry Market Estimate
  • Table 16.1: Fresenius' Medical Care in Asia, 2007 and 2008
  • Table 16.2: APP Pharmaceuticals Statistics, 2008
  • Table 17.1: Leading Global Medical Device Companies, 2008
  • Table A1.1: Turkish Medical Devices Export by Product Groups, 2003-2008
  • Table A2.1: Merger and Acquisition in Medical Device Sector, 2008
  • Table A5.1: Comparison of Cost for Medical Procedures
Back to Top